Johnson Matthey (JMPLY)
(Delayed Data from OTC)
$45.13 USD
-0.03 (-0.07%)
Updated Mar 28, 2024 02:53 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
JMPLY 45.13 -0.03(-0.07%)
Will JMPLY be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for JMPLY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for JMPLY
Johnson Matthey (JMPLY) Sells Medical Device Unit for $700M
Is Hawkins (HWKN) Stock Outpacing Its Basic Materials Peers This Year?
JMPLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Johnson Matthey (JMPLY) Stock Undervalued Right Now?
JMPLY vs. AIQUY: Which Stock Is the Better Value Option?
Should Value Investors Buy Johnson Matthey (JMPLY) Stock?
Other News for JMPLY
LONDON BROKER RATINGS: SocGen raises Sage; Numis cuts Virgin Money
Warning: JMPLY is at high risk of cutting its dividend
LONDON MARKET CLOSE: FTSE 100 treads water while Kering weighs on CAC
LONDON MARKET MIDDAY: Pre-Fed rate nerves push FTSE 100 in red
Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m